- 
				
Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease
 - 
				
Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
 - 
				
Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease
 - 
				
Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease
 - 
				
Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease
 - 
				
Using wavelet coherence analysis to distinguish between tremor types
 - 
				
Utility of IgGs subtypes in hemolytic anemia prevention and treatment maintenance in patients treated with continous infusion of apomorphine
 - 
				
Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy
 - 
				
Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital
 - 
				
Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
 
- « Previous Page
 - 1
 - …
 - 200
 - 201
 - 202
 - 203
 - 204
 - …
 - 207
 - Next Page »
 
